-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Researchers in my country have recently made new progress in the field of cerebral hemorrhage research, and found that intensive blood pressure reduction in the ultra-early stage can improve the treatment effect of cerebral hemorrhage and the accuracy of predicting the consequences, bringing new directions for the clinical treatment and scientific research of cerebral hemorrhage.
As one of the important developments in the field of cerebral hemorrhage in 2020, the related research results are included in the "2020 Acute Stroke Treatment Progress Special Report" by the international academic journal "Stroke".
Li Qi, the first author of the paper and associate professor of the Department of Neurology at the First Affiliated Hospital of Chongqing Medical University, introduced that previous studies have shown that intensive antihypertensive treatment is not beneficial to control hematoma enlargement or improve the poor prognosis of patients.
In response to this discovery, Li Qi came to Harvard University to repeatedly compare different blood pressure reduction programs for patients with cerebral hemorrhage, and put forward the concept of "intracerebral hemorrhage anti-hematoma expansion treatment time window", and found that strengthening blood pressure in the ultra-early stage can reduce the risk of hematoma enlargement and has Help predict the severity of illness.
The research was affirmed by the international authoritative stroke expert group.
